NCT07631962Completed
Impact of Radiotherapy on Survival in Breast Cancer Patients
Impact of Radiotherapy on Disease-Free and Overall Survival in Breast Cancer Patients: A Retrospective Cohort Study
Source: ClinicalTrials.gov · Last updated 8 Jun 2026
Brief summary (registry, in English)
In this study, using a large retrospective cohort, the investigators evaluate the impact of RT on disease-free survival and overall survival of patients with BC. The aim is to determine the true role of radiotherapy in improving patient outcomes and to provide a basis for designing more precise treatment strategies in the future.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1030 (actual)
- First submitted
- 28 May 2026
- Start date
- 1 Jan 1998
- Primary completion date
- 1 Feb 2008
- Lead sponsor
- Motamed Cancer Institute
- Diseases
- Childhood cancers
- NCT number
- NCT07631962
What you commit to
- Study type: Observational
- Participants enrolled: 1030
- From 1 Jan 1998 to the primary completion date, 1 Feb 2008
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Male patients.
- Patients with missing LPFS and OS information (zero encounter/follow-up).
Who the study is looking for
- -BC patients diagnosed between January 1998 and February 2008 in the Motamed Breast Cancer Research in Tehran, Iran.
Sex: Female · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.